mPharma the e-prescription startup that offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications.
mPharma's mission is to increase patient access to high quality medications.
mPharma was founded in 2014 by Gregory Rockson, Daniel Shoukimas and James Finucane. The company is headquartered in Accra, Ghana, with presence in Nigeria, Kenya, Zambia, Malawi, Rwanda and Ethiopia.
mPharma through their drug benefits service, offers a number of solutions to health insurance companies and pharmaceutical companies to make it easier for patients to afford their medications.
mPharma's Mutti pharmacies are essentially mini-hospitals offering a wide-range of services, including medical consultation, diagnostic and telehealth services. All these while increasing access and affordability to quality medication.
mPharma currently has 200 virtual centers across Africa. The company has helped over 1M patients make savings on high quality medicines.
mPharma is backed by CDC Group, JAM Fund, Unbound, Lux Capital, Northstar, Social Capital, Novastar, TO Ventures, Novartis CEO and chairman Daniel Vasella, Silicon Valley investor Jim Breyer, and others. The company raised $35M in Series D round on Jan 05, 2022. This brings mPharma's total funding to $88.2M to date.